Metagenomi Company
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.
Investors
Industry:
AI, End-to-end Drug Development, United States
Headquarters:
Emeryville, California, United States
Founded Date:
2018-01-01
Employees Number:
101-250
Funding Status:
Early Stage Venture
Investors Number:
28
Total Funding:
456973182
Estimated Revenue:
$1M to $10M
Last Funding Date:
2023-01-05
Last Funding Type:
Series B
Register and Claim Ownership